Multi-drug Resistant Tuberculosis in india

1233 Words5 Pages
The prevalence of multi-drug resistant tuberculosis has not only impacted India it has impacted other countries like Africa. Multi-drug resistant tuberculosis is when the regular medicine such as isoniazid and rifampicin one of the two anti-tuberculosis drugs used, the resistance can occur either through not following the proper treatment guidelines or from a drug resistant bacteria, tuberculosis can be caused from Mycobacterium Tuberculosis a bacteria that causes tuberculosis which attacks the lungs. Tuberculosis occurs through droplet infection and is extremely contagious, due the nature of being multi-drug resistant (MDR-TB) and extensively drug resistant (XDR-TB) many of the medications are expensive and hard to come by.…show more content…
The reason the WHO is requiring such guidelines is due to the fact the drug resistant tuberculosis arises from improper care and following of treatment by the patient, MDR-TB is common in people who did not follow treatment during their initial diagnosis of tuberculosis. Tuberculosis is affected by many socioeconomic factors. The low income individuals lack the necessary care and the health care facilities that are available to them, this can perturb the diagnosis of TB as well as MDR-TB. Poor living conditions often contribute the spread of the disease as overcrowding, poor ventilation and unsanitary water are associated with poor living conditions, the poor have an restricted amount of medication and treatment available to them as some medications and treatment are expensive and out of their reach. Due to treatment of tuberculosis many patients lose wages due to their need for stay in the hospital or the fact that the illness would cause a debilitating condition causing the person to stay off of work, the inadequate supply of money would cause the person to stop treatment. The Global Plan to Stop proposed by the WHO in 2006 reports that MDR-TB is requiring a raise in fund from 1 billion to 2 billion by 2015. MDR-TB is a large threat in the third world countries such as India as there are lack of health care that is provided for the cure of TB, funding and support from organizations such as the WHO have
Open Document